## Core Concept
Pulmonary hypertension is a condition characterized by elevated blood pressure in the pulmonary arteries, which can lead to right heart failure. The treatment involves drugs that specifically target the pulmonary vasculature to reduce pressure.

## Why the Correct Answer is Right
The correct answer, **Sildenafil**, is a phosphodiesterase type 5 (PDE5) inhibitor. PDE5 inhibitors work by increasing the levels of cyclic guanosine monophosphate (cGMP) in the pulmonary vasculature, leading to smooth muscle relaxation and vasodilation. This reduces pulmonary artery pressure and is beneficial in the treatment of pulmonary hypertension.

## Why Each Wrong Option is Incorrect
* **Option A:** This option is incorrect because, without specifying the drug, we cannot assess its relevance to pulmonary hypertension treatment.
* **Option B:** This option is incorrect because, similarly, without the drug name, its mechanism or use in pulmonary hypertension cannot be determined.
* **Option D:** This option is incorrect as it does not provide a drug that is recognized for the treatment of pulmonary hypertension.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **sildenafil**, commonly known for treating erectile dysfunction, also has a significant role in managing pulmonary arterial hypertension (PAH) by reducing pulmonary vascular resistance.

## Correct Answer Line
**Correct Answer: C. Sildenafil**.